Invention Grant
- Patent Title: Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a therapeutic strategy for Friedreich ataxia
-
Application No.: US17406441Application Date: 2021-08-19
-
Publication No.: US11873494B2Publication Date: 2024-01-16
- Inventor: Michael R. Green , Minggang Fang
- Applicant: University of Massachusetts
- Applicant Address: US MA Boston
- Assignee: University of Massachusetts
- Current Assignee: University of Massachusetts
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- The original application number of the division: US16487876
- Main IPC: C07K14/47
- IPC: C07K14/47 ; C12N15/113 ; A61K45/06
Abstract:
Methods of treating subjects having disorders associated with mutations in the FXN gene and/or having reduced expression of frataxin protein, e.g., Friedreich ataxia (FA). Generally, the methods include administering a therapeutically effective amount of an agent that increases expression of frataxin protein as described herein, e.g., an inhibitor of a FXN Repressing Factor (FXN-RF).
Information query
